LATEST #ATS2023 NEWS
Clinical Year in Review Begins with Latest Developments in ARDS, Pulmonary Vascular Disease, COPD, ILD
The first of four Clinical Year in Review sessions highlighted the latest papers published on acute respiratory distress syndrome, pulmonary vascular disease, chronic obstructive pulmonary disease, and interstitial lung disease. Stephanie Christenson, MD, MS, discussed new approaches to change the course of COPD recommended by the Lancet Commission and incorporated into the 2023 GOLD Report.
Experts Discuss Impactful Papers on Lung Cancer, COVID-19, Palliative Care, and Critical Care in Second Clinical Year in Review
The second session of the Clinical Year in Review explored the latest developments in lung cancer, COVID-19, palliative care, and critical care. Tiffanie Jones, MD, MPH, MSCE, discussed how early mobilization of patients in the intensive care unit affects ICU-acquired weaknesses.
International Respiratory Societies Gather to Discuss Inequities in COPD Treatment
The Respiratory Societies of the Americas kicked off its first in-person session at the ATS 2023 International Conference with representatives from four societies discussing COPD, its effects on country-specific populations, and the impact of health policies in relation to COPD. In Brazil, COPD is present in 6 percent of deaths, reported Frederico Fernandes, MD, PhD.
President’s Forum Focuses on Early Life Antecedents of Adult Lung Disease
Experts convened to explain the importance of early detection of prenatal and childhood respiratory illnesses and exposure to possible factors that could lead to adult respiratory disease. Some of these factors include airborne pollutants, viral infections like asthma, small airways disease, and COPD. Preterm birth exacerbates problems with pulmonary function across the lifespan, explained Kara N. Goss, MD.
Plenary Session Breaks Down Misinformation in Health Care and Welcomes New ATS President
The Plenary Session at the ATS 2023 International Conference raised the topic of misinformation in health care — with a few laughs along the way — from Keynote Speaker Timothy Caulfield, along with the installation of ATS President M. Patricia Rivera, MD, ATSF.
New ATS President Takes Collaborative Approach to Leadership
M. Patricia Rivera, MD, ATSF, the new president of the ATS for 2023-2024, shares inspirational influences in her life, her journey through the ATS, and the Society’s strategic framework for the coming year.
Panel of Health Care Experts Shares Insights into Advocacy for Reduction of Gun Violence
Panelists Joseph V. Sakran, MD, MPH, MPA; Emmy Betz, MD, MPH; and Fatimah L. Dreier, MSc, MBA, discussed their personal experiences with gun violence and how they were inspired to advocate for reform within the communities they serve.
Endobronchial Optical Coherence Tomography Wins BEAR Cage Competition
Sreyankar Nandy, MD, won the ATS 2023 Building Education to Advance Research (BEAR) Cage competition with his endobronchial optical coherence tomography concept for the early microscopic diagnosis and monitoring of interstitial lung disease. The three finalists were Marco Almeda, MD; Dr. Nandy; and Ananth Charya, MD, MS.
Early Career Programming Helps Young Professionals, Students Prep for Success
Hundreds of students and early career professionals got a head start on their ATS 2023 International Conference experience by taking part in specialty programming designed to elevate the next generation of respiratory clinicians and researchers.
On-Demand Highlights Extend ATS 2023 Learning for Dual Audiences
Over 100 scientific sessions from the ATS 2023 International Conference will be available for on-demand viewing. These sessions cover areas of pulmonary, critical care, and sleep medicine and will be accessible for viewing for one year to all who attended in person, as well as anyone who signs up for access through the ATS Store.